Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Renal Failure
Interventions
DRUG

LCP-Tacro tablets

Tacrolimus

DRUG

Prograf

Tacrolimus

Trial Locations (13)

10016

Clinical Investigative Site 00006, New York

14215

Clinical Investigative Site 000011, Buffalo

19104

Clinical Investigative Site 00003, Philadelphia

22903

Clinical Investigative Site 00001, Charlottesville

33606

Clinical Investigative Site 000002, Tampa

44095

Clinical Investigative Site 00008, Cleveland

48109

Clinical Investigative Site 000009, Ann Arbor

75246

Clinical Investigative Site 000013, Dallas

80045

Clinical Investigative Site 00004, Aurora

92123

Clinical Investigative Site 000015, San Diego

94115

Clinical Investigative Site 000012, San Francisco

40536-0293

Clinical Investigative Site 000005, Lexington

07039

Clinical Investigative Site 000010, Livingston

Sponsors
All Listed Sponsors
lead

Veloxis Pharmaceuticals

INDUSTRY